Emi Kobayashi

Thursday, 04 November 2021

Latest News for: emi kobayashi

Edit

U.S. FDA Approves Supplemental New Drug Application for Takeda’s ICLUSIG® (ponatinib) for Adult Patients with ...

Odessa American 19 Dec 2020

CAMBRIDGE, Mass. & OSAKA, Japan--(BUSINESS WIRE)--Dec 18, 2020--. Takeda Pharmaceutical Company Limited ( TSE.4502/NYSE.TAK ) today announced that the U.S ... “The FDA’s approval of this sNDA is a major milestone for the CML community ... About the OPTIC Trial ... WARNING ... Ltd ... Kazumi Kobayashi. kazumi.kobayashi@takeda.com ... Emy Gruppo. emy.gruppo@takeda.com ... PUB.

Edit

Takeda Oncology Demonstrates Leadership in Hematologic Cancers at 62nd American Society of Hematology (ASH) Annual Meeting

The Marshall News Messenger 05 Nov 2020

CAMBRIDGE, Mass. & OSAKA, Japan--(BUSINESS WIRE)--Nov 5, 2020--. ( ) (“Takeda”) today announced that it will present 22 company-sponsored abstracts at the 62nd American Society of Hematology (ASH) Annual Meeting, being held virtually December 5-8, 2020 ... Pevonedistat ... PML ... Kazumi Kobayashi. kazumi.kobayashi@takeda.com ... Emy Gruppo. emy.gruppo@takeda.com.

Edit

Canon India launches new offers on cameras, printers, other products: Details here

Live Mint 21 Oct 2020

With the ongoing Durga Puja and Navratri celebrations, the brand is also providing attractive EMI and cashback offers ... Kazutada Kobayashi, President and CEO, Canon India said, “Individuals and organizations across the world faced extraordinary circumstances this year due to ...

Edit

Takeda Announces Results from Phase 3 Clinical Trial Evaluating NINLARO™ (ixazomib) in Newly Diagnosed Multiple Myeloma

The Marshall News Messenger 10 Sep 2020

CAMBRIDGE, Mass. & OSAKA, Japan--(BUSINESS WIRE)--Sep 9, 2020-- ... These data will be presented at the virtual scientific meeting of the Society of Hematologic Oncology (SOHO) on Wednesday, September 9, 2020 at 6.15 p.m. CT ... About the TOURMALINE-MM2 Trial ... Renal Impairment ... Kazumi Kobayashi. kazumi.kobayashi@takeda.com ... Emy Gruppo. emy.gruppo@takeda.com.

Edit

Takeda Presents Positive Data from Clinical Trial Evaluating Oral NINLARO™ (ixazomib) in Multiple Myeloma as ...

Odessa American 12 Jun 2020

CAMBRIDGE, Mass. & OSAKA, Japan--(BUSINESS WIRE)--Jun 12, 2020--. Takeda Pharmaceutical Company Limited ( TSE.4502/NYSE.TAK ) (“Takeda”) today announced it will orally present the results of two studies at the 25th Congress of the European Hematology Association (EHA) ... Kazumi Kobayashi. kazumi.kobayashi@takeda.com ... Emy Gruppo. emy.gruppo@takeda.com.

Edit

Takeda Presents Positive Data from Clinical Trial Evaluating Oral NINLARO™ (ixazomib) in Multiple Myeloma as a First-Line Maintenance Therapy

Canada Dot Com 12 Jun 2020

− Positive Phase 3 Data Evaluating NINLARO as a Maintenance Therapy (TOURMALINE-MM4) Shows Significant Improvement in Progression-Free Survival in Adult Patients Not Treated with Stem Cell Transplantation ... CAMBRIDGE, Mass ... 95; p <0.001) ... Dimopoulos include ... 16%) ... Kazumi Kobayashi. kazumi.kobayashi@takeda.com ... Emy Gruppo. emy.gruppo@takeda.com.

Edit

Takeda Announces Compelling Data from the Phase 2 Trial of Pevonedistat Plus Azacitidine in Patients with Higher-Risk MDS

Canada Dot Com 29 May 2020

– Pevonedistat Combination Demonstrates the Potential to Double Complete Remissions and Improve Outcomes in HR-MDS, With Safety Profile Similar to Azacitidine Alone –. – Pevonedistat Could be First New Treatment Option for this Patient Population in More Than a Decade – ... Kazumi Kobayashi. kazumi.kobayashi@takeda.com ... Emy Gruppo. emy.gruppo@takeda.com.

Edit

Takeda to Present Data from the ICLUSIG® (ponatinib) Clinical Trial Program that Could Prove Practice-Changing ...

Odessa American 29 May 2020

CAMBRIDGE, Mass. & OSAKA, Japan--(BUSINESS WIRE)--May 29, 2020-- ... This dosing regimen resulted in an adjudicated arterial occlusive event (AOE) rate of 5.3% ... Takeda will be discussing these data with the U.S. Food and Drug Administration (FDA) ... Jorge Cortes, include ... Kazumi Kobayashi. kazumi.kobayashi@takeda.com ... Emy Gruppo. emy.gruppo@takeda.com ... PUB.

Edit

Takeda to Present Data from the ICLUSIG® (ponatinib) Clinical Trial Program that Could Prove Practice-Changing for the Treatment of Chronic-Phase CML

Canada Dot Com 29 May 2020

– Oral Presentations of the Phase 2 OPTIC Interim Analysis at the American Society of Clinical Oncology (ASCO) and the European Hematology Association (EHA) Annual Meetings – ... CAMBRIDGE, Mass ... Takeda will be discussing these data with the U.S ... WARNING ... Neuropathy ... Kazumi Kobayashi. kazumi.kobayashi@takeda.com ... Emy Gruppo. emy.gruppo@takeda.com.

Edit

Obituaries for February 20

Hawaii Tribune-Herald 20 Feb 2020

Survived by daughter, Ann (Stan) Okahara of Hilo; sons, Guy (Emi) Kobayashi of Kohala, Ken Kobayashi of Kona and Jay Kobayashi of Hilo; stepsons, Mach Fukada of Maui, Richard Fukada of California and Ray Fukada of Kohala; stepdaughter, Lani Fukada of Mainland; brother, Wayne ...

Edit

Obituaries: 02-20-20

West Hawaii Today 20 Feb 2020

Katsumi Kobayashi. Katsumi Kobayashi, 90, of Hawi died Jan ... He is survived by daughter, Ann (Stan) Okahara of Hilo; sons, Guy (Emi) Kobayashi of Kohala, Ken Kobayashi of Kona and Jay Kobayashi of Hilo; step-sons, Mach Fukada of Maui, Richard Fukada of Calif.

Edit

Japan's starting line-up against England in FIFA Women's World Cup Group D

China.dot.org 19 Jun 2019

Goalkeeper ... Defenders ... Midfielders. 6-Hina Sugita, 7-Emi Nakajima, 11-Rikako Kobayashi, 19-Jun Endo.

Edit

England-Japan Sums

This is Money 19 Jun 2019

Ayaka Yamashita; Nana Ichise, Saki Kumagai, Aya Sameshima; Jun Endo (Saori Takarada, 85th), Emi Nakajima, Risa Shimizu, Hina Sugita; Mana Iwabuchi, Rikako Kobayashi (Narumi ...

Edit

Japan-Scotland Sums

Reflector 14 Jun 2019

Scotland ... Ayaka Yamashita; Nana Ichise, Saki Kumagai, Aya Sameshima; Jun Endo (Rikako Kobayashi, 66th), Narumi Miura, Emi Nakajima, Risa Shimizu, Hina Sugita; Mana Iwabuchi (Yui Hasegawa, 82nd), Yuika Sugasawa ... .